insomnia
INSOMNIA

Insomnia can be either having difficulty in initiating sleep, maintaining sleep or experiencing early morning awakening wherein returning to sleep is not easily attained.

These disturbances can cause significant distress and impairment in daytime functioning.

It is the most prevalent sleep disorder in the general population thus accurate diagnosis and effective treatment is necessary.

Introduction

  • The subjective perception of difficulty in sleep initiation, duration, consolidation, or quality of sleep, occurring despite adequate opportunities for sleep, & resulting in daytime dysfunction
  • Insomnia is the most prevalent sleep disorder in the general population, therefore, it is an important public health problem that needs accurate diagnosis & effective treatment
  • Approximately 6-10% of adults have insomnia & it is more common in females & older adults
    • 30-50% of the population is affected by occasional, short-term insomnia
    • The prevalence of chronic insomnia disorder is estimated to be at least 5-10% in industrialized nations

Risk Factors

  • Increasing age
  • Female gender
  • Medical & psychiatric disease (eg depression, mood disorders)
  • Socioeconomic factors (eg marital separation, unemployment, lower quality of life)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
19 Sep 2016
Sertraline may prevent the onset of depressive disorders after traumatic brain injury (TBI), a randomized trial showed.
Tristan Manalac, 5 days ago
Daily engagement in brief, self-guided mindfulness and relaxation practices eases symptoms of borderline personality disorder in young adults, according to a recent Singapore study.
09 Oct 2016
The use of hormonal contraception increases the risk of subsequent use of antidepressants and a first diagnosis of depression, results of a study show.
01 Dec 2016
Vortioxetine 5-20 mg/day lessens depression and anxiety severity in patients with major depressive disorder (MDD) and high levels of anxiety, as observed in a meta-analysis of 10 randomised, placebo-controlled, 6/8-week trials.